PUBLICATIONS

• 2019
  Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
  Youn YC, Kang S, Suh J, Park YH, Kang MJ, Pyun J, Choi SH, Jeong JH, Park KW, Lee HW, An SSA, Jacqueline C Dominguez, Kim SY
• 2017
  Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
  Wang MJ, Yi SH, Han J, Park SY, Jang J, Chun IK, Kim SE, Lee BS, Kim GJ, Yu JS, Lim K, Kang SM, Park YH, Youn YC, An SSA, Kim SY
• 2017
  Dynamic changes of oligomeric amyloid β levels in plasma induced by spiked synthetic Aβ42
  An SSA, Lee BS,Yu JS, Lim K, Kim GJ, Lee R, Kim S, Kang S, Park YH, Wang MJ,Yang YS,Youn, YC, Kim S
• 2016
  Analysis of Cerebrospinal Fluid and [11C]PIB PET Biomarkers for Alzheimer‘s Disease with Updated Protocols
  Wang MJ,Yi S, Han JY,Park SY, Jang JW, Chun IK, Giau VV, Bagyinszky E, Lim KT, Kang SM, An SS, Park YH, Youn YC, Kim S
• 2016
  Droplet-based magnetic bead immunoassay using microchannel-connected multiwell plates(μCHAMPs) for the detection of amyloid beta oligomers
  Park MC,Kim M,Lim GT,Kang SM, An SS,Kim TS, Kang JY

01 02 03 04